Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard L Brien

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Trends in Molecular Medicine|March 20, 2019
The 3D Genome: EZH2 Comes into the FoldGerard L Brien, Adrian P Bracken
Seminars in Cell & Developmental Biology|August 18, 2009
Transcriptomics: unravelling the biology of transcription factors and chromatin remodelers during development and differentiationGerard L Brien, Adrian P Bracken
Cell Cycle (Georgetown, Tex.)|December 15, 2015
The PCL1-p53 axis promotes cellular quiescenceGerard L Brien, Adrian P Bracken
Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A Armstrong
Genes & Development|May 25, 2019
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancerAdrian P Bracken, Gerard L Brien, C Peter Verrijzer
Cancer Cell|April 13, 2016
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression ProgramsGerard L Brien, Daria G Valerio, Scott A Armstrong
Biorxiv : the Preprint Server for Biology|October 10, 2024
SUMO2 Inhibition Reverses Aberrant Epigenetic Rewiring Driven by Synovial Sarcoma Fusion Oncoproteins and Impairs SarcomagenesisRema Iyer, Anagha Deshpande, Aditi Pedgaonkar, et al.
Molecular & Cellular Proteomics : MCP|September 17, 2016
Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent CellsGiorgio Oliviero, Gerard L Brien, Ariane Waston, et al.
Angewandte Chemie (International Ed. in English)|April 19, 2017
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional LigandsDavid Remillard, Dennis L Buckley, Joshiawa Paulk, et al.
The EMBO Journal|August 13, 2025
Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesisRema Iyer, Anagha Deshpande, Aditi Pedgaonkar, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Trends in Molecular Medicine|March 20, 2019
The 3D Genome: EZH2 Comes into the FoldGerard L Brien, Adrian P Bracken
Seminars in Cell & Developmental Biology|August 18, 2009
Transcriptomics: unravelling the biology of transcription factors and chromatin remodelers during development and differentiationGerard L Brien, Adrian P Bracken
Cell Cycle (Georgetown, Tex.)|December 15, 2015
The PCL1-p53 axis promotes cellular quiescenceGerard L Brien, Adrian P Bracken
Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A Armstrong
Genes & Development|May 25, 2019
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancerAdrian P Bracken, Gerard L Brien, C Peter Verrijzer
Cancer Cell|April 13, 2016
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression ProgramsGerard L Brien, Daria G Valerio, Scott A Armstrong
Biorxiv : the Preprint Server for Biology|October 10, 2024
SUMO2 Inhibition Reverses Aberrant Epigenetic Rewiring Driven by Synovial Sarcoma Fusion Oncoproteins and Impairs SarcomagenesisRema Iyer, Anagha Deshpande, Aditi Pedgaonkar, et al.
Molecular & Cellular Proteomics : MCP|September 17, 2016
Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent CellsGiorgio Oliviero, Gerard L Brien, Ariane Waston, et al.
Angewandte Chemie (International Ed. in English)|April 19, 2017
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional LigandsDavid Remillard, Dennis L Buckley, Joshiawa Paulk, et al.
The EMBO Journal|August 13, 2025
Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesisRema Iyer, Anagha Deshpande, Aditi Pedgaonkar, et al.
Pageof 2